Effect of Hyperglycemia on Microvascular Perfusion in Healthy Adults

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

February 4, 2019

Primary Completion Date

April 1, 2021

Study Completion Date

April 1, 2021

Conditions
Vascular StiffnessInsulin Sensitivity
Interventions
DRUG

Octreotide

we are using it to block insulin secretion from the pancreas

DRUG

Insulin

we are using to replace basal insulin and in two protocols to raise insulin concentrations during the insulin clamp

DRUG

Dextrose 20% solution

We are using dextrose to maintain glycemia level

Trial Locations (1)

22908

University of Virginia, Charlottesville

All Listed Sponsors
collaborator

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

lead

University of Virginia

OTHER

NCT03520569 - Effect of Hyperglycemia on Microvascular Perfusion in Healthy Adults | Biotech Hunter | Biotech Hunter